Homing of radiolabelled recombinant interleukin-2 activated natural killer cells and their efficacy in adoptive immunotherapy against murine fibrosarcoma.

Abstract

Natural killer (NK) cells are spontaneously cytotoxic against tumour target cells. Their number was found to be four times more in the spleen of tumour-bearing Swiss albino mice. After activation with recombinant interleukin-2 (rIL-2), NK cells were tested and found to seek out the tumour site when injected intravenously in tumour-bearing mice. Their potential for fighting tumours in vivo was further seen following adoptive transfer of rIL-2 activated NK (A-NK) cells in tumour-bearing mice. After surgical removal of tumour load, adoptive transfer of A-NK cells inhibited tumour recurrence in 92.3%cases, thereby suggesting the use of this protocol for therapeutic purposes to obtain a better outcome.

• Authors: Anuradha Rai, Ashim K Chakravarty
• Journal: Journal of biosciences (J Biosci) Vol. 32 Issue 7 Pg. 1299-305 (Dec 2007) ISSN: 0250-5991 [Print] India
• PMID: 18202454 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Interleukin-2

Topics

• Animals
• Fibrosarcoma (immunology, therapy)
• Immunotherapy, Adoptive
• Interleukin-2 (immunology)
• Killer Cells, Natural (immunology)
• Mice
• Secondary Prevention
• Time Factors